VaramirStart free · no cardSign in
ARDX as of Nov 4 · 14:40 ET
ARDXNasdaqPharmaceutical Preparations

Ardelyx, Inc. · Brief

Next report

106 days

Feb 18 · after closeest.Q4 FY26
Earnings

Expected move

No implied move.

Implied vs realized

8 reportsHistory
7 of 8≥ implied
avg implied
±13.9%
avg realized
±16.7%
Feb 20 '25±8.2%▼−10.06%×1.22
May 1 '25±19.2%▼−24.50%×1.27
Aug 4 '25±15.1%▲+16.86%×1.12
Q3 FY25±14.0%▲+20.96%×1.50
Jan 8 '26±14.2%▲+20.07%×1.42
Feb 19 '26±12.6%▼−14.99%×1.19
Q1 FY26±13.4%▲+8.69%×0.65
Q2 FY26±14.2%▼−17.86%×1.25
quarterimplied−25%0+25%realized×
Q2 FY26±14.2%▼−17.86%×1.25
Q1 FY26±13.4%▲+8.69%×0.65
Feb '26±12.6%▼−14.99%×1.19
Jan '26±14.2%▲+20.07%×1.42
Q3 FY25±14.0%▲+20.96%×1.50
Aug '25±15.1%▲+16.86%×1.12
2 older reports
May '25±19.2%▼−24.50%×1.27
Feb '25±8.2%▼−10.06%×1.22
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Feb 18 report · est.

—

Linked exposure

ARDX report session

No linked exposure.

Latest changes

30 daysAll changes
Nov 3impliedImplied move: ±16.8% into Nov 3 earnings (Nov 3 close).Source
Oct 30impliedImplied move: ±14.0% into Nov 5 earnings (Oct 30 close).Source
Oct 15impliedImplied move: ±13.8% into Oct 29 earnings (Oct 15 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.